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The high molecular weight chemotactic factor, C567,  derived from the fifth, sixth, 
and seventh components of complement, induces chemotaxis in rabbit polymorphonu- 
clear leukocytes by activating a  serine esterase  (1,  2).  1 This  esterase is capable of 
splitting acetyl DL-phenylalanine/3-naphthyl ester; it exists in or on the polymorpho- 
nuclear leukocyte in an inert form termed proesterase 1; the active form is known as 
esterase 1 (3, 4). 
C567  incubated with the rabbit  polymorphonuclear leukocyte changes the cell in 
such a manner that it no longer is capable of giving a chemotactic response; this spe- 
cific decrease in chemotactic responsiveness is called "deactivation" (2). The activation 
of proesterase 1 is involved in the deactivation by C567  (2). If a cell is deactivated by 
C567 it will not respond chemotactically to the other complement-derived chemotactic 
factors (C3a, CSa) nor to bacterial chemotactic factors; that is, it is deactivated to all 
of them (5). Similarly, if a cell is deactivated by C3a or CSa, it is also deactivated to 
all the others including the bacterial factors. However, incubation of rabbit polymor- 
phonuclear leukocytes with bacterial factor does not induce deactivation to either the 
bacterial factor not to any of the complement-derived factors (5). 
Previous work on the involvement of proesterase 1 in the chemotaxis of the poly- 
morphonuclear leukocyte and its activation had been done only with C567.  Thus, the 
question remained as to whether the other chemotactic factors, C3a and C5a, and bac- 
terial factors induce chemotaxis in  the  neutrophil by activating proesterase  1.  The 
work to be described was undertaken in order to answer this question. 
In  this study,  it  is shown  that  the  p-nitrophenyl ethyl  phosphonate  esters 
give the  same kind of what  we have  called (1)  chemotactic  factor-dependent 
inhibition of chemotaxis when C3a, CSa, or a  bacterial agent is the chemotactic 
factor as when C3-6--7  is employed. This pattern and kind of inhibition indicates 
a requirement for the activation of proesterase 1 in the chemotactic response to 
C567  (1)  and pari passu indicates the same sort of requirement in the chemo- 
* Supported in part by US Public Health Service Grant AI-09648. 
I Whether C5-67 transforms proesterase  1 to esterase  1 directly or indirectly is not known. 
In what follows, the term "activation" will not necessarily imply direct activation. 
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tactic response to  C5a  and the bacterial factor. However,  when the activation 
of proesterase  1  was  directly tested by measuring the acetyl nL-phenylalanine 
~-naphthyl  esterase  activity  of  leukocytes  with  and  without  contact  with 
chemotactic factor, it was found that  a  measurable  activation of proesterase  1 
could  be  demonstrated  in cells treated  with  C3a,  C5a,  or C567 but  not  with 
bacterial factor. The implications of these observations in regard to enzymatic 
mechanisms  associated  with chemotaxis will be presented. 
Materials  and  Methods 
Buffers.--Medium  199  (Baltimore Biological Laboratories,  Cockeysville,  Md.)  buffered 
with 0.02 ~  tris (hydroxymethyl) aminomethane (Tris) (Sigma Chemical Co., St. Louis, Mo.) 
was used for deactivation studies. Hanks' buffered salt solution with 2 mg/mi added glucose 
was used for chemotactic studies where no preincubations of cells was involved. Unpublished 
work has shown that cells incubated at room temperature before chemotactic assay retained 
their chemotactic responsiveness better in Medium 199 than in Hanks' buffer. However, the 
chemotactic responsiveness of cells which were not preincubated was essentially the same in 
either buffer. In all cases, chemotaxis was performed with cells suspended in 0.1% bovine serum 
albumin (BSA)  2 (fraction V, Pentex Biochemical, Kankakee, Ill.). The buffer for esterase as- 
says was TGS buffer, Tris 0.02 M, pH 7.3, in 0.15 ~f saline with 0.1% added gelatin. 
Phosphonates.--The  p-nitrophenyl ethyl chloroalkylphosphonates and  the p-nitrophenyl 
alkylphosphonates were the same as described previously (1). They were dissolved in acetone 
as a 0.1 ~ stock solution. The phosphonates were diluted to 0.67 mM in Hanks' buffer just before 
use, and then an equal volume of inhibitor and cells were added, the mixture was immediately 
placed in the upper compartment of the chemotaxis chamber after the chemotactic agent had 
been added in the lower compartment. The chamber was then placed at 37°C as rapidly as pos- 
sible. Cells suspended in Hanks' buffer containing 0.33% acetone were used as controls. Previ- 
ous work had shown that 0.5%  acetone had no effect on the chemotactic responsiveness of 
polymorphonuclear leukocytes to C567  (1) and preliminary work confirmed an absence of an 
effect of 0.5% acetone on the responsiveness of the cells to C3a, C5a, and bacterial factor. 
Chemotactic Factors.--The  C3a and CSa were prepared by the digestion of highly purified 
human C3 and C5 with twice-crystallized trypsin (6). The trypsin was 4% by weight of the C3 
and 2% by weight of the C5. In each case, the complement components were incubated with 
the trypsin for 15 min at room temperature. The reaction was stopped by the addition of a 
four times greater weight than the added trypsin of crystalline soybean trypsin inhibitor. The 
amount of C3a or C5a employed in any experiment is reported in terms of the amount of C3 
or C5, respectively, used in preparation of the given fragment. The control was C3a or C5 
incubated for 15 min to which trypsin was added after the soybean trypsin inhibitor. 
The bacterial factor was a crude culture filtrate of Escherichia coli prepared as described in 
reference 7. 
The C567 was a  euglobulin preparation from human serum activated by sensitized sheep 
erythrocyte stromata containing the first live components of rabbit complement as described 
in reference 8. The nonactivated C567 was simply the same euglobulin which had not incubated 
with sensitized sheep stromata. 
Polymorphonudear Leukocytes.--The  rabbit peritoneal polymorphonuclear leukocytes were 
obtained in primed animals by the injection of 0.5-1 liter of 0.02% glycogen in sterile saline. 
The peritoneal exudate was obtained from the rabbits 12 hr later. The polymorphonuclear 
leukocytes made up 85-95% of the cells of the exudate. 
2 Abbre,,iations used in this paper: BSA, bovine serum albumin; TGS, 0.02 M Tris, pH 7.3, in 
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Cells for esterase assay were obtained by bleeding the rabbit from the central ear artery 
into 1/40 mg the volume of 0.15 ~  ethylenediamlnetetraacetate  (EDTA), pH 7.3. The white 
cells were largely freed from the red cells by mixing 1 volume of blood with 1 volume of 2% 
gelatin in 0.15 ~ saline. The mixture was incubated  at 37°C for 45  min, and the supernatant 
drawn off and centrifuged at room temperature for 10 rain at 600 g. The cells were then sus- 
pended in 5 ml of Medium 199 and treated at room temperature for 15 min with p-nitrophenyl 
ethyl 5-chloropentylphosphonate at a final concentration of 5  X  10  -5 M in order to destroy 
all of the already activated esterase 1 and esterase 2 (2, 3). They were then washed twice with 
200 ml of TGS and suspended in Medium 199 containing 0.1% bovine serum albumin at a con- 
centration of 2  X  107 polymorphonuclear leukocytes/ml. 
The leukocyte suspension contained variable numbers of red cells; the white cells were in 
the same proportions as in the original blood. Extensive work reported previously (4) showed 
the esterase activity was attributable only to the polymorphonuclear leukocytes of the mixture 
so no further purification was attempted. 
Chemototaclic Assay.--This was performed as described previously (1). 
Esterase A ssay.--The assay for esterase activity was somewhat modified from that described 
previously (4). To 0.1 ml of cells containing 2  X  106 polymot~phonuclear  leukocytes obtained 
from the blood was added 0.4 ml of substrate (8 mg of acetyl 3L-phenylalanine fl-naphthyl ester 
(Schwarz Bio Research Inc., Orangeburg, N.Y.) dissolved in 3 ml dimethylformamide and 6 
ml of acetone and diluted 1:10 in TGS). The mixture was incubated at 37°C in a shaking water 
bath. Mter 45 min the reaction was stopped by the addition of 1 ml of acetone. The precipi- 
tated protein and cellular debris were centrifuged off and to the acetone supernatant was added 
0.1  ml of diazonium coupling reagent  (11.5 ml fast scarlet in 5 ml of water). Any  turbidity 
which developed was removed by centrifugatlon. The orange-red color which formed as a prod- 
uct of the coupling of the liberated/~-naphthol with the diazonium salt was read at 485 nm in 
a  Gilford 300-N spectrophotometer (Gilford  Instrument Laboratories Inc., Oberlin, Ohio). 
RESULTS 
Phosphonate Inhibition.--The  results  of  studies  of  the  chemotactic  factor- 
dependent  inhibition  by  the  series of p-nitrophenyl  ethyl  chloroalkylphospho- 
hates and p-nitrophenyl ethyl alkylphosphonates  are seen in Fig. 1. As is evident 
from Fig.  1,  when either C3a,  C5a,  or bacterial factor are used  as chernotactic 
agents,  the  peak  inhibitory  activity  in  the  chloroalkylphosphonate  series  is 
shown  by  the  p-nitrophenyl  ethyl  4-chlorobutylphosphonate  and  by  the  p- 
nitrophenyl ethyl bntylphosphonate  in the alkylphosphonate  series. Two other 
experiments  not shown here carried  out with both  C5a  and bacterial  factor as 
the chemotactic agents gave the same results  as seen in Fig.  1. 
The structure activity relationships  (inhibition profiles) seen in Fig. 1 are the 
same as found when these same series  of  phosphonates  are  used to  inhibit  the 
chemotactic response  to C567  (1).  Such inhibition profiles have been shown to 
be due to the inhibition of the  activatable  esterase  of chemotaxis  (proesterase 
1)  (1-4). 
Activation  of Proesterase  /.--Numerous  attempts  failed  to  demonstrate  an 
increase  in  acetyl DL-pheny]alanine  3-naphthyl  esterase  activity of peripheral 
blood polymorphonuclear leukocytes after incubation with varying dilutions  of 
bacterial factor.  In these experiments,  0.1  ml of blood leukocytes treated with 
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cytes were incubated at room temperature with varying dilutions of either bac- 
terial factor, C~,  or the nonactivated C567. At the end of 20 min, 2 ml of ice- 
cold Medium 199 with 0.1% BSA was added,  the tubes were centrifuged in the 
cold and the supernatant  discarded.  The cells  were resuspended in 0.1  ml  of 
Medium 199 containing 0.1% BSA and then 0.4 ml substrate was added and the 
assay for esterase conducted as described. 
Table I  shows the results of two such experiments in which the dilutions of 
bacterial factor were varied over a 160-fold range. In no instance was there any 
evidence of esterase activation by the bacterial factor. In neither instance could 
this be attributed to a lack of proesterase 1 in the cells used or an inherent inabil- 
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FIG. i.  Profiles  of chemotactlc factor-dependent inhibition  by p-nitrophenyl ethyl alkyl- 
phosphonates and p-nitrophenyl ethyl chloroalkylphosphonates using either C3a (200 pg/ml): 
C5a (I0 vg/ml), or bacterial factor (1/100) as the chemotactic stimulant. 
ity of the proesterase to be activated. C5--~ used at a concentration previously 
found  to  give  chemotactic  deactivation  gave  significant  esterase  activation 
(Table I) of the same cells  and under the same circumstances where the bac- 
terial  factor  failed  to  give  demonstrable  activation 
In the experiments of Table I, although testing of the bacterial factor for its 
ability to activate proesterase 1 of the leukocyte was done over a wide range of 
concentrations, only one time and temperature of incubation, 20 rain and room 
temperature, respectively, were employed. It was therefore considered possible 
that the use of other time intervals or other temperatures of incubation might 
give different results.  To test this possibility, experiments were carried out as 
described for the studies recorded in Table I except that 0.2 ml volumes of buffer 
of 1:20 or 1:100 dilutions of bacterial factor added to  0.1  ml  of  rabbit  blood 
polymorphonuclear leukocytes  (2  X  107/ml  polymorphonuclear  leukocytes) 
were incubated for either 5, 20, 40, or 60 rain at room temperature or for 20 rain 
at 37°C, 30°C, or room temperature. 380  PROESTERASE  1  ACTIVATION  BY  CHEMOTACTIC  AGENTS 
As seen  in Table  II, varying  the  time  or  temperature  of incubation  of bac- 
terial factor with cells still did not result in any demonstrable  activation of pro- 
esterase  L 
The  same  experiments  employing  C5a  as  the  activating  agent  (Table  III) 
gave distinctly different results than when bacterial factor was used.  The  exper- 
iments were carried out essentially as described using the bacterial factor. How- 
ever, since we had previously shown with C567 that the activation of proesterase 
1 was demonstrable only when the extent of chemotactic deactivation was 50 % 
or greater (4),  it  was  felt to be  of interest to see if  this  same  relationship  held 
TABI, E  I 
Comparison of Esterase .t ctivation by C567 and by Bacterial Factor 
Experi-  Substance added to cells  Fsterase  activity OD at  A OD 
merit  485 nm ~  SD 
0.4 ml buffer  0.307  4- 0.022  (N =  12) 
0.4 ml C567  0.345  4- 0.0035  (N  =  2)  0.038 * 
04  ml C567  0.317  4- 0.017  (N =  2)  0.010 
0.4 ml bacterial factor 1:5  0.283 ~  0.00424  (N  =  2)  --0.024 
0.1 ml  ....  1:5  0.317  4- 0.013  (N  =  2)  0.010 
0.4 ml  ....  l:t00  0.289 4- 0.023  (N  =  2)  --0.018 
0.4 ml buffer  0.249 4- 0.0205  (N  =  12) 
0.4 ml C567  0.308 4- 0.016  (N =  2)  0.059{ 
0.4 ml C567  0.260 !  0.064  (N  =  2)  0.011 
0.4 ml bacterial factor 1:100  0.241  4- 0.0028  (N  =  2)  --0.008 
0.2 ml  ......  0.234 4- 0.025  (N  =  2)  --0.015 
0.1  ml  ......  0.255 4- 0.028  (N  =  2)  0.006 
0.05 ml  ......  0.247  4- 0.0071  (N =  2)  --0.002 
* Difference is statistically significant,  P  <  0.05. 
{ Difference is statistically highly significant, P  <  0.01. 
when activation was attempted  with  a  complement-derived  factor  other  than 
C567. Therefore,  the procedure  was slightly modified so that  the cells could be 
tested  both  for  proesterase  activation  and  chemotactic  deactivation.  For  this 
purpose,  0.2 ml of peripheral blood leukocytes containing 4  X  106 polymorpho- 
nuclear  leukocytes  were  incubated  for  20  rain  with  the  agents  given in Table 
III. After the cells were washed  they were suspended  in 0.2 ml of Medium  199 
with  added  0.1 ~:,{ BSA. Of the 0.2  ml of cell suspension,  0.1  ml was  employed 
for the  assay  of  residual  chemotactic  responsiveness  (deactivation)  using  a  1: 
100 dilution of bacterial factor and the other 0.1  ml was tested for esterase  ac- 
tivity. 
As is evident from Table III, significant esterase activation was  achieved by 
CSa in both experiments. The activation was specific; equivalent amounts of C5 
from which  the CSa was produced failed to activate. Those ceils which showed ELMER  L.  BECKER  381 
significant esterase  activation also showed concomitant  deactivation.  As men- 
tioned,  in previous  work  it had  been found  that  unless  the  C567  deactivated 
the cells to the extent of 50 %  or more, it was not possible to discern significant 
activation  of  esterase  (4).  The  results  of  Table  III  confirm  this.  Incubation 
with 50 gg equivalent of C5a resulted in no deactivation (experiment A) and no 
significant degree of esterase activation was found. However,  100 gg equivalent 
TABLE  II 
Effect of Variations in the Time and  Temperature  of Incubation of Bacterial Factor with Rabbit 
Blood Polymorphonuclear Leukocytes on the Activation of Proesterase 1 
Experi-  Time of incuba-  Esterase  activity 4- sn 
mental  tion  OD 485 nm 
min 
A  5 
20 
40 
60 
Temperature of 
incubation 
Room tem- 
perature 
30°C 
37°C 
0.2 mlbuffer  0.145  4-  0.017  (N  =  4) 
0.2 ml 1:100 bacterial factor  0.125  -4-  0.018  (N  =  2) 
0.2 ml 1:20  "  '  "  0.153  4-  0.0014  (N =  2) 
0.2 mlbuffer  0.162  -4-  0.011  (N  =  4) 
0.2 ml 1:100 bacterial factor  0.147  -4-  0.000  (N  =  2) 
0.2 ml 1:20  "  "  0.163  4-  0.019  (N  =  2) 
0.2 mlbuffer  0.153  -4-  0.015  (N  =  4) 
0.2 ml 1:100 bacterial factor  0.145  4-  0.020  (N  =  2) 
0.2 ml 1:20  ....  0.153  -4-  0.025  (N  =  2) 
0.2 mlbuffer  0.177  4-  0.024  (N  =  4) 
0.2 ml 1:100 bacterial factor  0.172  4-  0.006  (N  =  2) 
0.2 ml 1:20  ....  0.174  -4-  0.007  (N  =  2) 
0.2 ml buffer  0.262  4-  0.019  (N  =  4) 
0.2 ml 1:100 bacterial factor  0.264  ±  0.006  (N  =  2) 
0.2 ml 1:20  ....  0.264  4-  0.020  (N  =  2) 
0.2 ml buffer  0.282  4-  0.028  (N  =  4) 
0.2 ml 1:100 bacterial factor  0.263  4-  0.006  (N  =  2) 
0.2 ml 1:20  "  "  0.304  4-  0.039  (N  --  2) 
0.2 ml buffer  0.295  4-  0.054  (N  =  4) 
0.2 ml 1:100 bacterial factor  0.280  4-  0.034  (N  =  2) 
0.2 mI 1:20  "  "  0.248  ±  0.019  (N  =  2) 
of C5a produced cells which were 57 %  deactivated and showed significant ester- 
ase activation. In experiment B, incubation of the cells with  100 ~g equivalent 
of C5a resulted in only 35 %  deactivation and no significant proesterase activa- 
tion, whereas,  200 ~g equivalent of CSa gave cells which were 62 %  deactivated 
and exhibited sigificant proesterase activation. Table III  also shows the sort of 
variation that was seen from one experiment to another. The cells used in exper- 
iment A  required only half the amount  of C5a to give the same degree of deac- 
tivation and esterase activation as was necessary with the cells of experiment B. 382  PROESTERASE  1  ACTIVATION  BY  CHEMOTACTIC  AGENTS 
In another experiment not shown here, 200 ~g equivalent of C5a gave no deac- 
tivation and no esterase activation. The reason for this variability is unknown, 
but was also seen previously when C5--67 was the chemotactic agent used (4). 
C3a was also tested for its ability to give activation of proesterase 1 by adding 
varying volumes of C3a, C3, or buffer to 0.1 ml of 2 )<  106 peripheral blood poly- 
morphonuclear leukocytes in Medium 199 containing  0.1% BSA and incubating 
for 20 rain at room temperature. The cells were then treated, centrifuged, and 
tested for esterase activation as described. From the results seen in Table IV it 
TABLE  III 
Activation of Proesterase 1 and Chemotactlc Deactivation by C5a 
Chemotactlc 
Experi-  Substance added  Esterase  activity (OD  activity  Deactiva- 
meat  to cells  at 485 nm 4- sD)  A OD  (cells/  tion§ 
3HPF) 
A  Buffer  0.249  4-  0.0084  (N  =  6)  109 
50/zg C5a*  0.248  .4-  0.015  (N  =  2)  --0.001  116  0 
50 #g C5  0.265  4-  0.013  (N  =  2)  0.017  137  0 
100 ~g C5a  0.284  .4-  0.0085  (N  =  2)  0.035~  47  57 
100/zg C5  0.247  .4-  0.0042  (N  =  2)  --0.002  129  0 
Buffer  0.264  .4- 0.0075  (N  =  6)  110 
100/~g CSa  0.272  -4- 0.016  (N  =  2)  0.008  71  35 
100/zg C5  0.246  -4- 0.012  (N  =  2)  --0.018  135  0 
200/zg C5a  0.295  -4- 0.023  (N  =  2)  0.031~t  42  62 
200/~g C5  0.260  .4- 0.011  (N  =  2)  --0.004  113  0 
* The amount of C5a is given in terms of the amount of C5 from which the C5a was pro- 
duced. 
:~ Difference from  mean  esterase activity of  buffer control  is  statistically  significant, 
P  <  0.01. 
(chemotactic activity of control  ceils -  chemotactic 
activity of treated cells) 
§ Per  cent deactivation  =  100 
chemotactic activity of control cells 
is evident that a  sufficiently high concentration of C3a induced significant ac- 
tivation of proesterase  1. 
The Chemotactic Activity of C567, C5a, and C3a Relative to Bacterial Factor.- 
The proesterase 1 content of rabbit peripheral blood polymorphonuclear leuko- 
cytes is higher than that of the corresponding peritoneal leukocytes and this is 
associated with a higher chemotactic activity of the blood leukocytes compared 
to the peritoneal cells (4).  On this basis, if the bacterial factor  activates less 
proesterase 1 than does C3a, C5a, or C567 as suggested by the results described 
so far, it also might give less maximal chemotactic activity than the three com- 
plement-derived chemotactic factors. To explore this possibility, rabbit perito- 
neal polymorphonuclear leukocytes were  suspended in 0.1~4  BSA  in Hanks' ELMER  L.  BECKER  383 
buffer at a  concentration of 3.0  X  106/ml and tested for chemotactic activity 
in the usual way with varying concentrations of C3a, CSa, C567,  and bacterial 
factor. The results are seen in Figs. 2 and 3. 
The plateau in chemotactic activity from a  }~0  dilution of  bacterial factor 
to a  a/{oo dilution evident in Figs. 2 and 3 has been seen repeatedly,  although 
the level of maximum activity attained varies from experiment to experiment. 
TABLE IV 
Activation  of Proesterase 1 by C3a 
Substance added to cells  Esterase activity (OD  at 485 nm 4-  SD)  A OD 
Buffer  0.188  4-  0.0165 
160/zg C3a*  0.184  ±  0.012  0 
160/zg C3  0.174  4- 0.0078 
500/~g C3a  0.198  4-  0.0014  0.010 
500/zg C3  0.182  4-  0.0084 
1000 #g C3a  0.215  4-  0.0063  0.027:[: 
1000/zg C3  0.172  4-  0.0019 
*iThe amount of C3a is given in terms of the amount of C3 from which  the C3a was 
produced. 
:~ Difference  from  mean  esterase  activity of  buffer  control is  statistically  significant, 
P  <  0.05. 
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Comparison of the chemotactic activity of C5a, C567, and  bacterial factor (BF). 
Whether the inhibition at higher concentrations of bacterial factor is due to an 
impurity present in the crude culture filtrate which is the source of the bacterial 
factor i s not known. However, Dr. P. A. Ward in a  personal communication has 
stated  that  he  has  found  the  same  inhibition  using  highly  purified  factor 
suggesting  it may be  an  intrinsic property of the factor.  With either  C5a or 
C567  (Fig. 2) no such plateau of inhibition was evident. In view of the purpose 
of the experiments, the most important point, however, is that the maximum 
activity attainable by the bacterial factor is distinctly less than  the maximal 
activity attained by either C56--7 or C5a (Fig. 2). The same results were obtained 384  PROESTEP.AS.E  1  ACTIVATION BY  CIIEMOTACTIC AGENTS 
in  another  experiment not  shown  here,  in  which  the  chemotactic  activity of 
bacterial  factor and  CSa  were compared. Here also  a  plateau of chemotactic 
activity was evident with the bacterial factor; however, in this experiment the 
activity given by 100 ~g equivalent of C5 was distinctly greater than that given 
by 200  /zg equivalent of CSa  (496  cells/3HPF  compared to 237  cells/3HPF). 
Nevertheless, the maximal activity given by the bacterial factor was even less, 
183 cells/3HPF. 
The chemotactic activity of C3a was compared in the same way with that of 
the bacterial factor with the same results. As seen in Fig. 3, the maximum ac- 
tivity of the bacterial factor was reached  between  a  1~o  and  }~00  dilution. 
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Cnmparison of the chemotactic activity of C3a and bacterial factor (BF). 
This activity was distinctly less than that reached bv 1000/ag/ml equivalent of 
C3a, the highest concentration of C3a tested. The larger amounts of C3a than 
CSa (expressed in amounts of the complement component used to produce the 
fragment) required  to give chemotactic activity greater than the maximal ac- 
tivity of the bacterial factor (Fig.  2 compared with Fig. 3)  mirrors the larger 
amounts of C3a required  to activate proesterase 1 (Table III compared with 
"Fable IV). 
DISCUSSION 
The profiles of inhibition by the  p-nitrophenyl ethyl alkylphosphonates and 
the  p-nitroptaenyl ethyl chloroalkylphosphonates when C3a, C5a, and the bac- 
terial factor are used as the chemotactic agents are the same as those found when 
chemotaxis is induced by C567  (1), or in the prevention of deactivation by C567 
(2) or in the inhibition of esterase 1 (3, 4). The essential idenity of the inhibition 
profiles given by the two series of phosphonates under all of these circumstances 
implies that like the chemotactic response to C567, chemotaxis induced by C3a, ELMER  L.  BECKER  385 
C5a, or bacterial factor involves, as a necessary step, an activation of proester- 
ase 1. The finding that CSa and C3a activate proesterase 1, as measured by the 
increase of acetyl DL-phenylalanine/$-naphthyl esterase activity (Tables III and 
IV), is direct confirmation of this conclusion as far as  C3a and CSa are con- 
cerned.  However,  this  conclusion  is  seemingly  contradicted  when  bacterial 
factor is employed since under no circumstance could activation of proesterase 
1  be  demonstrated  bv  direct  measurement  of  acetyl  nL-phenylalanine 3- 
naphthyl esterase activity using bacterial factor as the stimulus  (Tables I  and 
II). 
The hypothesis best explaining this seeming contradiction is that the activa- 
tion of proesterase 1 of the polymorphonuclear leukocyte is an essential step in 
the chemotactic response to all the chemotactic agents, C567, CSa, C3a, and the 
bacterial factor. However, there  are quantitative  differences  in  the  ability of 
these substances to activate proesterase 1. The bacterial factor, for reasons un- 
known, activates a much smaller portion of the proesterase 1 of the cell than do 
the complement-derived factors. The amount activated by the bacterial factor 
is sufficient  for the cell to respond chemotactically but insufficient to be detect- 
ible by direct biochemical assay. 
This hypothesis not only explains the observations recorded here but also ex- 
plains  the  observations of Ward on  the  inability  of bacterial  factor to  deac- 
tivate to itself or the other complement-derived factors, although the comple- 
ment-derived factors can deactivate to themselves,  to each other,  and  to the 
bacterial factor (5).  As already demonstrated,  activation of proesterase  1 is a 
necessary step in deactivation (2).  Since,  by hypothesis, bacterial factor acti- 
vates only a very small proportion of proesterase  1 when incubated with the 
leukocyte, it always leaves enough proesterase  1 so that sufficient  is available 
for a chemotactic response to either fresh bacterial factor, or to one or another 
of the complement-derived factors. Thus, it neither deactivates to itself nor to 
the other factors. Yet, the activation of proesterase 1 is a required step in the 
chemotactic response of the cell to bacterial factor as well as to the complement- 
derived factors (Fig. 1 and reference 1). If sufficient  proesterase 1 is used up by 
prior contact with one or another of the complement-derived factors, the cell 
will not have sufficient  proesterase 1 to be activated by either the bacterial fac- 
tors or the other factors. Thus, the cell deactivated to  one of the complement- 
derived factors will not only be deactivated to itself and to the other factors, but 
to the bacterial factor as well. 
The quantitative difference  in the response of the proesterase  1 of blood poly- 
morphonuclear leukocyte to  the  bacterial  factor  and  to  the  other  factors  is 
analogous to the difference in the response of the proesterase 1 of the blood and 
peritoneal polymorphonuclear leukocyte to C567.  The chemotactic response of 
the peritoneal leukocyte to C567 operates through activation of proesterase 1 as 
shown by the inhibition profiles  with the phosphonate esters (1). Yet, no direct 
biochemical activation of proesterase  1 by measurement  of acetvl DL-phenyl- 386  PROESTERASE  1  ACTIVATION BY  CHEMOTACTIC  AGENTS 
alanine ~3-naphthyl esterase activity can be demonstrated with these cells; it is 
necessary to test the peripheral blood leukocytes in order to show activation by 
direct  biochemical measurement.  Although  the  two  situations  are  analogous 
they are not identical. The bacterial factor activates only a small proportion of 
the  proesterase  1  on  the  cell  whether  it  is  a  peripheral  blood  leukocyte 
or a peritoneal leukocyte. C567, on the other hand, presumably activates a high 
proportion of the proesterase on the cells from the two sources, but the perito- 
neal cell has distinctly less proesterase 1 than the peripheral blood leukocyte. 
As shown previously, the presence of a larger amount of proesterase 1 on the 
blood polymorphonuclear leukocyte than  on the  peritoneal  leukocyte that  is 
capable of being activated is  associated with  a  greater degree of chemotactic 
activity of the  former compared with  the  latter  (4).  This  association is  also 
present when the chemotactic activity of bacterial factor and of C3a, C5a, and 
C567 are compared (Tables I, III, and IV and Figs. 2 and 3). As is evident from 
Figs. 2 and 3, the maximal chemotactic activity attainable with bacterial factor 
is distinctly less than that obtained with an  5  , of the three complement-derived 
factors. Why there should be inhibition at the higher concentrations of bacterial 
factor, whether it is due to an inhibitor present in the crude culture filtrate or is 
an intrinsic property of the bacterial factor, is not known. The results obtained 
here suggest that, whatever the reason, the lower maximal activity of the bac- 
terial factor compared with the activity attainable bv C3a, CSa, or C567 is due 
to the lesser degree of activation of proesterase 1, induced by the bacterial fac- 
tor. Thus, the results obtained in this work not only indicate that the activation 
of  proesterase  1  is  a  general  requirement  for  chemotactic  activity  with 
the known macromolecular agents, but suggest that under several different cir- 
cumstances the level of chemotactic activity attained is related to the degree of 
such activation. 
SUMMARY  AND  CONCLUSIONS 
The inhibition  profiles obtained when a series of p-nitrophenyl ethyl alkyl- 
phosphonates and of p-nitrophenyl ethyl chloroalkylphosphonates were used to 
interfere with the chemotactic activity of polymorphonuclear leukocytes stimu- 
lated by C3a, CSa, and bacterial factor were the same as found previously when 
C5-67 was the chemotactic agent. This indicates that as in the chemotactic ac- 
tivity induced by C567,  an obligatory step in the chemotaxis caused by C3a, 
CSa,  and bacterial factor is the activation of proesterase 1 of the rabbit poly- 
morphonuclear leukocyte. 
CSa  and  C3a activate proesterase  1 of peripheral  blood polymophonuclear 
leukocytes as measured by the increase of acetyl DL-phenylalanine ~-naphthyl 
esterase activity. Attempts to detect in a like manner the proesterase 1 of the 
same leukocytes using bacterial factor under varying circumstances have con- 
sistently failed.  It is concluded  that bacterial  factor, for unknown  reasons, is ELMER  L.  BECKER  387 
unable to activate proesterase  1 to the same extent as the complement-derived 
chemotactic factors. 
The hypothesis of there being a quantitative  difference in the ability of bac- 
terial  factor to activate proesterase  1 compared with  the complement-derived 
factors explains  the  previous observations that bacterial  factor can not deac- 
tivate to itself or to the complement-derived factors, although these latter fac- 
tors  can deactivate  to themselves,  to each  other,  and  to the  bacterial  factor. 
The quantitative  difference in the ability of bacterial factor to activate pro- 
esterase  1 compared to the complement-derived factors is also associated with 
and explains the finding that the maximal chemotactic activity attainable when 
bacterial  factor is  the  chemotactic  agent  is  distinctly  less than  that  obtained 
using either C3a, C5a, or C567. 
These results indicate that the activation of proesterase 1 is a general require- 
ment for the chemotactic activity of rabbit polymorphonuclear leukocytes with 
known macromolecular chemotactic agents and suggest that under several dif- 
ferent circumstances the level of chemotactic activity attained is related to the 
degree of such activation. 
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